SGLT2 inhibitors are a class of drugs that are approved to lower the blood glucose levels of people with Type 2 diabetes. Doctors have identified…
Category: Products & Tech
TheU.S. FDA has approved Rybelsus (semaglutide), the first and only glucagon-like peptide-1 (GLP-1) analog in a pill.
“GLP-1 receptor agonists…
On the heels of the approval of nasal glucagon, the FDA has approved Xeris Pharmaceuticals’ ready-to-use, room-temperature stable liquid…
Who’s got your back? Who have you trained on your emergency Glucagon kit? When you – or the person with Type 1 diabetes in your life – has a severe hypo,…
In a time when the insulin price crisis in America has become a such prominent news story, it’s easy to lose sight of the global scope of the issue.…
On June 13, the New York Times published a video op-ed with a stark title: “We Either Buy Insulin or We Die.” The video explores the realities of life…
The U.S. Food and Drug Administration (FDA) has approved Lilly’s BAQSIMI (glucagon) nasal powder 3 mg for the treatment of severe hypoglycemia…
“Very few companies would make the bet that we’re making,” Kevin Sayer.
In the first half of our interview with Dexcom CEO Kevin Sayer, we…
ASweetLife was lucky enough to score an interview with Kevin Sayer, the President & CEO of Dexcom.
We are publishing our interview in two parts.…
On June 27, 2019, the FDA issued a warning patients and health care providers that certain Medtronic MiniMed™ insulin pumps have potential cybersecurity…